| Evolocumab and clinical outcomes in patients with cardiovascular disease MS Sabatine, RP Giugliano, AC Keech, N Honarpour, SD Wiviott, ... New England journal of medicine 376 (18), 1713-1722, 2017 | 5612 | 2017 |
| Lixisenatide in patients with type 2 diabetes and acute coronary syndrome MA Pfeffer, B Claggett, R Diaz, K Dickstein, HC Gerstein, LV Køber, ... New England Journal of Medicine 373 (23), 2247-2257, 2015 | 2508 | 2015 |
| Rivaroxaban in patients with a recent acute coronary syndrome JL Mega, E Braunwald, SD Wiviott, JP Bassand, DL Bhatt, C Bode, ... New England Journal of Medicine 366 (1), 9-19, 2012 | 2448 | 2012 |
| Effects of dalcetrapib in patients with a recent acute coronary syndrome GG Schwartz, AG Olsson, M Abt, CM Ballantyne, PJ Barter, J Brumm, ... New England Journal of Medicine 367 (22), 2089-2099, 2012 | 2263 | 2012 |
| Long-term use of ticagrelor in patients with prior myocardial infarction MP Bonaca, DL Bhatt, M Cohen, PG Steg, RF Storey, EC Jensen, ... New England Journal of Medicine 372 (19), 1791-1800, 2015 | 2152 | 2015 |
| Follow-up of blood-pressure lowering and glucose control in type 2 diabetes S Zoungas, J Chalmers, B Neal, L Billot, Q Li, Y Hirakawa, H Arima, ... New England Journal of Medicine 371 (15), 1392-1406, 2014 | 820 | 2014 |
| Cardiovascular efficacy and safety of bococizumab in high-risk patients PM Ridker, J Revkin, P Amarenco, R Brunell, M Curto, F Civeira, ... New England Journal of Medicine 376 (16), 1527-1539, 2017 | 657 | 2017 |
| The prognostic value of pre-operative and post-operative B-type natriuretic peptides in patients undergoing noncardiac surgery: B-type natriuretic peptide and N-terminal … RN Rodseth, BM Biccard, Y Le Manach, DI Sessler, GA Lurati Buse, ... Journal of the American College of Cardiology 63 (2), 170-180, 2014 | 373 | 2014 |
| Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial SJ Nicholls, JJP Kastelein, GG Schwartz, D Bash, RS Rosenson, ... Jama 311 (3), 252-262, 2014 | 331 | 2014 |
| Myocardial infarction after percutaneous coronary intervention: a meta-analysis of troponin elevation applying the new universal definition L Testa, WJ Van Gaal, GGL Biondi Zoccai, P Agostoni, RA Latini, ... QJM: An International Journal of Medicine 102 (6), 369-378, 2009 | 247 | 2009 |
| Colchicine in patients with acute coronary syndrome: the Australian COPS randomized clinical trial DC Tong, S Quinn, A Nasis, C Hiew, P Roberts-Thomson, H Adams, ... Circulation 142 (20), 1890-1900, 2020 | 238 | 2020 |
| Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study C Cavallini, S Savonitto, R Violini, G Arraiz, M Plebani, Z Olivari, ... European heart journal 26 (15), 1494-1498, 2005 | 237 | 2005 |
| Plaque volume and occurrence and location of periprocedural myocardial necrosis after percutaneous coronary intervention: insights from delayed-enhancement magnetic resonance … I Porto, JB Selvanayagam, WJ Van Gaal, F Prati, A Cheng, K Channon, ... Circulation 114 (7), 662-669, 2006 | 230 | 2006 |
| Effect of losmapimod on cardiovascular outcomes in patients hospitalized with acute myocardial infarction: a randomized clinical trial ML O’Donoghue, R Glaser, MA Cavender, PE Aylward, MP Bonaca, ... Jama 315 (15), 1591-1599, 2016 | 216 | 2016 |
| Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome GG Schwartz, AG Olsson, CM Ballantyne, PJ Barter, IM Holme, D Kallend, ... American heart journal 158 (6), 896-901. e3, 2009 | 216 | 2009 |
| The Syntax score predicts peri-procedural myocardial necrosis during percutaneous coronary intervention WJ van Gaal, FA Ponnuthurai, J Selvanayagam, L Testa, I Porto, ... International journal of cardiology 135 (1), 60-65, 2009 | 172 | 2009 |
| With the “universal definition,” measurement of creatine kinase-myocardial band rather than troponin allows more accurate diagnosis of periprocedural necrosis and infarction … CCS Lim, WJ van Gaal, L Testa, F Cuculi, JR Arnold, T Karamitsos, ... Journal of the American College of Cardiology 57 (6), 653-661, 2011 | 158 | 2011 |
| The role of intravascular ultrasound in the management of spontaneous coronary artery dissection JR Arnold, NEJ West, WJ van Gaal, TD Karamitsos, AP Banning Cardiovascular ultrasound 6, 1-7, 2008 | 150 | 2008 |
| Percutaneous treatment of chronic total coronary occlusions improves regional hyperemic myocardial blood flow and contractility: insights from quantitative cardiovascular … ASH Cheng, JB Selvanayagam, M Jerosch-Herold, WJ van Gaal, ... JACC: Cardiovascular Interventions 1 (1), 44-53, 2008 | 141 | 2008 |
| Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo R Bentley-Lewis, D Aguilar, MC Riddle, B Claggett, R Diaz, K Dickstein, ... American heart journal 169 (5), 631-638. e7, 2015 | 120 | 2015 |
Italo Porto,Full Professor of Cardiovascular Diseases, Policlinico San Martino IRCCS, Università di GenovaVerified email at unige.it
